Danaher Invests in AI Healthcare Company

Dow Jones05:47

By Connor Hart

Two Danaher subsidiaries have formed what the company called an investment partnership with Innovaccer, a healthcare artificial-intelligence company.

The partnership aims to improve patient outcomes and experiences through novel digital and diagnostic solutions, the companies said Thursday. It will additionally seek to accelerate the adoption of precision diagnostics by clinicians and population health teams.

Terms of the partnership weren't disclosed.

Innovaccer builds software that creates a unified patient record, which the company said allows it to use AI to identify gaps in care and patients who are at risk, as well as appropriate interventions to improve outcomes.

Washington, D.C.-based Danaher said the investment aligns with its mission to accelerate the transition to precision medicine with AI-enabled diagnostics.

Before the market closed Innovaccer said it raised $275 million in a Series F funding round. Investors included B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente and M12.

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

January 09, 2025 16:47 ET (21:47 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment